Antidepressant prescribing practices of outpatient psychiatrists

Archives of General Psychiatry

Volumn 55, Issue 4, 1998, Pages 310-316

  Olfson, Mark ^a   Marcus, Steve C ^b   Pineus, Harold Alan ^c   Zito, Julie M ^d   Thompson, James W ^d   Zarin, Deborah A ^c  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRESCRIPTION; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY;

ADJUSTMENT DISORDERS; ADOLESCENT; ADULT; AGE FACTORS; AGED; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS; CHILD; CONFIDENCE INTERVALS; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; OFFICE VISITS; PERSONALITY DISORDERS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PSYCHIATRY; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 0031946148     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.55.4.310     Document Type: Article

References (52)

1. Hume AL, Barbour MM, Lapane KL, Carleton RA. Is antidepressant use changing? prevalence and clinical correlates in two New England communities. Pharmacotherapy. 1995;15:78-84.
2. Baum C, Kennedy DL, Knapp DE. Juergens JP, Faich GA. Prescription drug use in 1984 and changes over time, Med Care. 1988;26:105-114.
3. Huszonek JJ. Dewan MJ, Koss M, Hardoby WJ, Ispahani A. Antidepressant side effects and physician prescribing patterns. Ann Clin Psychiatry. 1992;5:7-11.
4. Olfson M, Klerman GL, Trends in the prescription of psychotropic medications: the role of physician specialty. Med Care. 1993;31:559-564.
5. Olfson M, Klerman GL. Trends in the prescription of antidepressants by office-based psychiatrists. Am J Psychiatry. 1993;150:571-577.
6. Cowley G. The culture of Prozac. Newsweek. February 7, 1994:41-42.
7. Kramer PD. Listening to Prozac. New York, NY: Viking Penguin; 1993.
8. Messiha FS. Fluoxetine: a spectrum of clinical applications and postulates of underlying mechanisms, Neuro Sci. Biobehav Rev. 1993;17:385-396.
9. Schappart SM. National Ambulatory Medical Care Survey: 1994 Summary. Hyattsville, Md: National Center for Health Statistics; 1996. Advance Data From Vital and Health Statistics, No. 273.
10. Potthoff RF, Woodbury MA, Manton KG. "Equivalence sample size" and "equivalent degrees of freedom" refinements for inference using survey weights under superpopulation models. J Am Stat Assoc. 1992;87:383-396.
11. Robins LN, Regier DS, eds. Psychiatric Disorders in America. New York, NY: Free Press; 1991.
12. US Bureau of the Census, Statistical Abstract of the United States: 1996. 116th ed, Washington, DC: US Bureau of the Census; 1996.
13. Shore MF, Beigel A. The challenges posed by managed behavioral health care. N Engl J Med. 1996;334:116-118.
14. Olfson M, Pincus HA, Outpatient psychotherapy in the United States, II: patterns of utilization. Am J Psychiatry. 1994;151:1289-1294.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987.
16. Lahey BB, Loeber R, Stouthamer-Loeber M, Christ MA, Green S, Russo MF, Frick PJ, Dulcan M. Comparison of DSM-III and DSM-III-R diagnoses for prepubertal children: changes in prevalence and validity. J Am Acad Child Adolesc Psychiatry. 1990;29:620-626.
17. Akiskal KS. Dysthymia: clinical and external validity. Acta Psychiatr Scand. 1994;383(suppl):19-23.
18. Hirschfeld RM, Holzer CE. Depressive personality disorder: clinical implications. J Clin Psychiatry. 1995;55(suppl):10-17.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
20. Kaplan SL, Simms RM, Busner J. Prescribing practices of outpatient child psychiatrists. J Am Acad Child Adolesc Psychiatry. 1994;33:35-44.
21. Bramble DJ. Antidepressant prescription by British child psychiatrists: practice and safety issues. J Am Acad Child Adolesc Psychiatry. 1995;34:327-331.
22. Fisher RL, Fisher S. Antidepressants for children: is scientific support necessary? J Nerv Ment Dis. 1996;184:99-102.
23. Ryan NO, The pharmacologic treatment of child and adolescent depression, Psychiatr Clin North Am. 1992;15:29-40.
24. Geller B, Cooper T, Graham D, Marsteller F, Bryant M. Double-blind placebocontrolled study of nortriptyline in depressed adolescents using a "fixed plasma level" design, Psychopharm Bull. 1990;26:85-90.
25. Kramer A, Feiguine R. Clinical effects of amitriptyline in adolescent depression. J Am Acad Child Psychiatry. 1981;20:636-644.
26. Kutcher S, Boulos C, Ward B, Marton P, Simeon J, Ferguson HB, Szalai J, Katic M, Roberts N, Dubois C, Reed K, Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial, J Am Acad Child Adolesc Psychiatry. 1994;33:686-694.
27. Simeon J, Dinicola V, Ferguson H, Copping W. Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up. Prog Neuropsychopharmacol Biol Psychiatry. 1990;14:791-795.
28. Kye CH, Waterman GS, Ryan ND, Birmaher B, Williamson DE, Iyenger S, Dachille S. A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression. J Am Acad Child Adolesc Psychiatry. 1996;35:1139-1144.
29. Thurber S, Ensign J, Punnett AF, Welter K. A meta-analysis of antidepressant outcome studies that involved children and adolescents. J Clin Psychol. 1995;51:340-345.
30. Medawar C, Through the doors of deception? Nature. 1994;368:369-370.
31. Barondes SH.Thinking about Prozac.Science. 1994;263:1102-1103.
32. Manolis DC, The perils of Prozac, Minn Med. 1995;78:19-23.
33. Pande AC, Sayler ME. Severity of depression and response to fluoxetine. Int Clin Psychopharmacol. 1993;8:243-245.
34. Montgomery SA. The advantages of paroxetine in different subgroups of depression. Int Clin Psychopharmacol. 1992;6:91S-100S.
35. Rost K, Smith R, Matthews DB, Guise B. The deliberate misdiagnosis of major depression in primary care, Arch Fam Med. 1994;3:333-337.
36. Rosenberg RL. Drug treatment of panic disorder. Pharmacol Toxicol. 1993;73:344-353.
37. Schweizer E, Rickeis K, Weiss S, Zavodnick S, Maintenance drug treatment of panic disorder, I: results of a prospective, placebo-controlled comparison of alprazolam and imipramine, Arch Gen Psychiatry. 1993;50:51-60.
38. Piccinelli M, Pini S, Bellantuono C, Wilkinson G. Efficacy of drug treatment in obsessive-compulsive disorder: a meta-analytic review. Br J Psychiatry. 1995;16:424-443.
39. Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF. Efficacy of phenelzine and haloperidol in borderline personality disorder, Arch Gen Psychiatry. 1993;50:377-385.
40. Smellie JM, McGrigor VS, Meadow SR, Rose SJ, Douglas MF. Nocturnal enuresis: a placebo controlled trial of two antidepressant drugs, Arch Dis Child. 1996;75:62-66.
41. Wilens TE, Biederman J, Geist DE, Stengard R, Spencer T. Nortriptyline in the treatment of ADHD: a chart review of 58 cases. J Am Acad Child Adolesc Psychiatry. 1994;33:142-143.
42. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB, A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA. 1996;275:761-767.
43. Miller NS. Pharmacotherapy in alcoholism. J Addict Dis. 1995;14:23-46.
44. Gawin FH, Kleber HD, Byck R, Rounsaville BJ, Kosten TR, Jatlow PI, Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry. 1989;46:117-121.
45. Siris SG, Bermanzohn PC, Mason SE, Shuwall MA. Maintenance imipramine therapy for secondary depression in schizophrenia: a controlled trial, Arch Gen Psychiatry. 1994;51:109-115.
46. Siris SG, Adjunctive medication In the maintenance treatment of schizophrenia and its conceptual implications. Br J Psychiatry. 1993;22(suppl):66-78.
47. American Psychiatric Association, Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry. 1994;151 (suppl 12):1-36.
48. Sturm R, Meredith LS, Wells KB, Provider choice and continuity for the treatment of depression. Med Care. 1996;34:723-734.
49. Brown SL, Salive ME, Gralnik JM, Pahor M, Chapman DP, Blaxer D. Antidepressant use in the elderly: association with demographic characteristics, health-related factors, and health care utilization. J Clin Epidemiol. 1995;48:445-453.
50. Olfson M, Klerman GL. The treatment of depression: prescribing practice of primary care physicians and psychiatrists. J Fam Pract. 1992;35:627-635.
51. Rosenheck R, Fontana A, Cottrol C. Effect of clinician-veteran racial pairing in the treatment of posttraumatic stress disorder. Am J Psychiatry. 1995;152:555-563.
52. Olfson M, Pincus HA, Dial TH. Professional practice patterns of US psychiatrists. Am J Psychiatry. 1994;151:89-94.